CSS
NVS icon

Cubist Systematic Strategies’s Novartis NVS Stock Holding History

Cubist Systematic Strategies’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-56,891
Closed -$5.54M – 3319
2024
Q4 		$5.54M Buy
+56,891
New +$6.07M 0.03% 778
2024
Q2 		– Sell
-142,265
Closed -$13.8M – 3714
2024
Q1 		$13.8M Buy
142,265
+87,081
+158% +$8.93M 0.08% 336
2023
Q4 		$5.57M Buy
55,184
+23,827
+76% +$2.3M 0.04% 808
2023
Q3 		$3.19M Sell
31,357
-61,100
-66% -$6.2M 0.02% 1037
2023
Q2 		$9.33M Buy
92,457
+91,057
+6,504% +$9.11M 0.06% 469
2023
Q1 		$129K Sell
1,400
-6,212
-82% -$543K ﹤0.01% 3384
2022
Q4 		$691K Sell
7,612
-46,284
-86% -$3.9M ﹤0.01% 2774
2022
Q3 		$4.1M Sell
53,896
-9,538
-15% -$791K 0.02% 1276
2022
Q2 		$5.36M Buy
63,434
+26,138
+70% +$2.29M 0.03% 928
2022
Q1 		$3.27M Sell
37,296
-102,529
-73% -$8.88M 0.03% 1073
2021
Q4 		$12.2M Buy
139,825
+129,992
+1,322% +$10.8M 0.12% 155
2021
Q3 		$804K Sell
9,833
-23,207
-70% -$2.09M 0.01% 1690
2021
Q2 		$3.02M Buy
33,040
+10,721
+48% +$955K 0.03% 829
2021
Q1 		$1.91M Buy
22,319
+20,182
+944% +$1.81M 0.02% 1069
2020
Q4 		$202K Sell
2,137
-1,881
-47% -$164K ﹤0.01% 2233
2020
Q3 		$349K Buy
4,018
+314
+8% +$27.2K 0.01% 1930
2020
Q2 		$324K Sell
3,704
-12,456
-77% -$1.08M 0.01% 1821
2020
Q1 		$1.33M Sell
16,160
-9,209
-36% -$822K 0.04% 662
2019
Q4 		$2.4M Buy
25,369
+20,465
+417% +$1.84M 0.04% 645
2019
Q3 		$426K Sell
4,904
-2,585
-35% -$232K 0.01% 1375
2019
Q2 		$684K Sell
7,489
-104
-1% -$8.8K 0.01% 1280
2019
Q1 		$654K Sell
7,593
-6,499
-46% -$522K 0.02% 1010
2018
Q4 		$1.08M Sell
14,092
-3,441
-20% -$268K 0.05% 530
2018
Q3 		$1.35M Sell
17,533
-5,499
-24% -$407K 0.07% 344
2018
Q2 		$1.56M Buy
23,032
+16,008
+228% +$1.1M 0.08% 323
2018
Q1 		$509K Sell
7,024
-208
-3% -$15.8K 0.03% 786
2017
Q4 		$544K Buy
7,232
+3,473
+92% +$262K 0.03% 839
2017
Q3 		$289K Sell
3,759
-26,141
-87% -$1.97M 0.02% 1200
2017
Q2 		$2.24M Sell
29,900
-12,034
-29% -$853K 0.14% 162
2017
Q1 		$2.79M Buy
41,934
+34,866
+493% +$2.32M 0.2% 88
2016
Q4 		$461K Sell
7,068
-3,926
-36% -$255K 0.04% 710
2016
Q3 		$778K Sell
10,994
-2,561
-19% -$187K 0.05% 517
2016
Q2 		$1M Buy
+13,555
New +$936K 0.06% 443
2016
Q1 		– Sell
-4,425
Closed -$341K – 1766
2015
Q4 		$341K Sell
4,425
-32,649
-88% -$2.59M 0.02% 1043
2015
Q3 		$3.05M Buy
37,074
+14,014
+61% +$1.25M 0.15% 127
2015
Q2 		$2.03M Buy
23,060
+5,298
+30% +$486K 0.1% 272
2015
Q1 		$1.57M Buy
17,762
+9,312
+110% +$826K 0.08% 377
2014
Q4 		$702K Sell
8,450
-4,246
-33% -$352K 0.04% 693
2014
Q3 		$1.07M Buy
12,696
+7,685
+153% +$622K 0.07% 436
2014
Q2 		$406K Buy
+5,011
New +$394K 0.02% 831

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cubist Systematic Strategies's NVS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Novartis (NVS) in Q1 2025, closing a stake of 56,891 shares — an estimated $5.54M sold.

Cubist Systematic Strategies first reported a position in NVS in Q2 2014 and held it in 40 quarters. The position peaked at $13.8M in Q1 2024. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 56,891 Novartis shares in Q1 2025, an estimated $5.54M.
  • Cubist Systematic Strategies first reported a position in Novartis in Q2 2014 and held it in 40 quarters.
  • Cubist Systematic Strategies's Novartis position peaked at $13.8M in Q1 2024.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.